| 000 | 01784 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517033658.0 | ||
| 264 | 0 | _c20160429 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.3903 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhoo, Bee Luan | |
| 245 | 0 | 0 |
_aShort-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. _h[electronic resource] |
| 260 |
_bOncotarget _cJun 2015 |
||
| 300 |
_a15578-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEpithelial-Mesenchymal Transition _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Dosage _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKeratins _xmetabolism |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 |
_aNeoplastic Cells, Circulating _xpathology |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 |
_aSpheroids, Cellular _xpathology |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aLee, Soo Chin | |
| 700 | 1 | _aKumar, Prashant | |
| 700 | 1 | _aTan, Tuan Zea | |
| 700 | 1 | _aWarkiani, Majid Ebrahimi | |
| 700 | 1 | _aOw, Samuel G W | |
| 700 | 1 | _aNandi, Sayantani | |
| 700 | 1 | _aLim, Chwee Teck | |
| 700 | 1 | _aThiery, Jean Paul | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 17 _gp. 15578-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.3903 _zAvailable from publisher's website |
| 999 |
_c24932725 _d24932725 |
||